Cargando…
Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcom...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442076/ https://www.ncbi.nlm.nih.gov/pubmed/37158157 http://dx.doi.org/10.1097/JS9.0000000000000467 |
_version_ | 1785093507656974336 |
---|---|
author | Lu, Junlin Zhao, Yang Zhang, Hongqi Li, Tianxiao Song, Donglei Guan, Sheng Maimaitili, Aisha Wang, Yunyan Feng, Wenfeng Wang, Yang Wan, Jieqing Mao, Guohua Shi, Huaizhang Yang, Xinjian Liu, Jianmin Zhao, Yuanli |
author_facet | Lu, Junlin Zhao, Yang Zhang, Hongqi Li, Tianxiao Song, Donglei Guan, Sheng Maimaitili, Aisha Wang, Yunyan Feng, Wenfeng Wang, Yang Wan, Jieqing Mao, Guohua Shi, Huaizhang Yang, Xinjian Liu, Jianmin Zhao, Yuanli |
author_sort | Lu, Junlin |
collection | PubMed |
description | BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcome rates, as well as the learning curve for PED. METHODS: A total of 217 patients were consecutively enroled from four eligible centres and divided into three groups based on the number of procedures performed: group 1 (first 10 procedures), group 2 (11–20 procedures), and group 3(>20 procedures). Major complications include operation-related ischaemic or haemorrhagic events and mass effect deterioration. Poor outcome was defined as a modified Rankin Scale score greater than 2 at discharge. Cumulative summation (CUSUM) analysis was generated to assess the learning curve according to major complications and poor outcome. RESULTS: The study found that major complications and poor outcomes occurred in 5.1% and 2.3% of cases, respectively. The rate of major complications decreased from 10.0% in group 1 to 2.9% in group 3 (P=0.053), while the rate of poor outcomes decreased from 7.5% in group 1 to 0.7% in group 3 (P=0.015). Multivariable regression analysis adjusted for covariates showed that operator experience was associated with a lower rate of poor outcomes (P=0.034). CUSUM analysis demonstrated that the learning curve for avoiding major complications and poor outcomes required 27 (mean=13) and 40 (mean=20) cases, respectively. CONCLUSIONS: These findings suggest that PED treatment requires a learning curve of 40 cases to achieve reproducibility regarding complications and functional results. Additionally, major complications and poor outcomes significantly decreases after the first 20 procedures. CUSUM analysis can serve as a useful tool for monitoring and assessing surgical performance. |
format | Online Article Text |
id | pubmed-10442076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104420762023-08-22 Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study Lu, Junlin Zhao, Yang Zhang, Hongqi Li, Tianxiao Song, Donglei Guan, Sheng Maimaitili, Aisha Wang, Yunyan Feng, Wenfeng Wang, Yang Wan, Jieqing Mao, Guohua Shi, Huaizhang Yang, Xinjian Liu, Jianmin Zhao, Yuanli Int J Surg Original Research BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcome rates, as well as the learning curve for PED. METHODS: A total of 217 patients were consecutively enroled from four eligible centres and divided into three groups based on the number of procedures performed: group 1 (first 10 procedures), group 2 (11–20 procedures), and group 3(>20 procedures). Major complications include operation-related ischaemic or haemorrhagic events and mass effect deterioration. Poor outcome was defined as a modified Rankin Scale score greater than 2 at discharge. Cumulative summation (CUSUM) analysis was generated to assess the learning curve according to major complications and poor outcome. RESULTS: The study found that major complications and poor outcomes occurred in 5.1% and 2.3% of cases, respectively. The rate of major complications decreased from 10.0% in group 1 to 2.9% in group 3 (P=0.053), while the rate of poor outcomes decreased from 7.5% in group 1 to 0.7% in group 3 (P=0.015). Multivariable regression analysis adjusted for covariates showed that operator experience was associated with a lower rate of poor outcomes (P=0.034). CUSUM analysis demonstrated that the learning curve for avoiding major complications and poor outcomes required 27 (mean=13) and 40 (mean=20) cases, respectively. CONCLUSIONS: These findings suggest that PED treatment requires a learning curve of 40 cases to achieve reproducibility regarding complications and functional results. Additionally, major complications and poor outcomes significantly decreases after the first 20 procedures. CUSUM analysis can serve as a useful tool for monitoring and assessing surgical performance. Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10442076/ /pubmed/37158157 http://dx.doi.org/10.1097/JS9.0000000000000467 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Original Research Lu, Junlin Zhao, Yang Zhang, Hongqi Li, Tianxiao Song, Donglei Guan, Sheng Maimaitili, Aisha Wang, Yunyan Feng, Wenfeng Wang, Yang Wan, Jieqing Mao, Guohua Shi, Huaizhang Yang, Xinjian Liu, Jianmin Zhao, Yuanli Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title | Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title_full | Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title_fullStr | Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title_full_unstemmed | Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title_short | Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study |
title_sort | learning curve in pipeline embolization device: results from the pipeline embolization device in china post-market multicentre registry study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442076/ https://www.ncbi.nlm.nih.gov/pubmed/37158157 http://dx.doi.org/10.1097/JS9.0000000000000467 |
work_keys_str_mv | AT lujunlin learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT zhaoyang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT zhanghongqi learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT litianxiao learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT songdonglei learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT guansheng learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT maimaitiliaisha learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT wangyunyan learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT fengwenfeng learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT wangyang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT wanjieqing learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT maoguohua learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT shihuaizhang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT yangxinjian learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT liujianmin learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy AT zhaoyuanli learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy |